2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Polycystic Ovary Syndrome
13
Obesity
6
Weight Loss
5
Overweight
3
Menstruation Disturbances
2
Intermittent Fasting
2
Insulin Resistance
2
Tumor Surgery
1
Sarcopenia
1
Postoperative Complications
1
Obesity, Abdominal
1
Muscle Weakness
1
Motor Activity
1
Moderately Overweight Individuals
1
Metabolic Syndrome
1
Metabolic Diseases
1
Infertility
1
Glucocorticoid Receptor Deficiency
1
Fasting
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Breast Cancer Female
1
Body Weight
1
Interventions
fludarabine
2
Metformin
2
Busulfan
2
thymoglobulin
1
fludarabine phosphate
1
bicalutamide
1
Testosterone
1
Saline Solution
1
Powders
1
Nutrition Assessment
1
Mesna
1
Melphalan
1
Magnetic Resonance Imaging
1
Influenza Vaccines
1
Honey
1
Heparin
1
Gonadotropin-Releasing Hormone
1
Gastric Bypass
1
Exercise
1
Eating
1
Cyclophosphamide
1
Clofarabine
1
Caloric Restriction
1
Antineoplastic Agents
1
Antilymphocyte Serum
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Metabolic Diseases
×
Caloric Restriction
×
Clear all
NCT02449148
2022-01-13
HELENA
German Cancer Research Center
Phase NA
Completed
150 enrolled